hims - Search News

News

Novo Nordisk, Hims & Hers Health

Novo Nordisk ends collaboration with Hims & Hers

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap knock-offs of the weight loss drug Wegovy, it said on Monday.

Reuters on MSN · 1h

Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug

COPENHAGEN (Reuters) -Drugmaker Novo Nordisk said on Monday it would halt its Wegovy weight-loss drug agreement with U.S. telehealth company Hims & Hers Health, pushing Hims shares down 31% in morning trading.

Hims & Hers stock plummets after Novo Nordisk ends Wegovy direct sales deal

Hims & Hers stock plummeted around 30% in early trading Monday after Novo Nordisk announced it was ending a collaboration to make its blockbuster, Wegovy, availab

StockStory.org on MSN49m

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker ...

2h

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its ...

2h

Stock Movers: Northern Trust, XOM, HIMS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

Daily Voice on MSN1h

Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results